Hims & Hers Health is trading 3.33% down at €24.40 after coverage said the FTC lawsuit reveal drove the stock sharply lower.
- September 15, 2026 coverage highlighted a securities class action alleging misleading privacy, billing, and cancellation disclosures.
- The FTC separately alleges sensitive health information was shared with advertising platforms.
- The broader market was essentially flat; trading was closed at the provided timestamp, with no additional company announcement identified.